Added to YB: 2025-05-07
Pitch date: 2025-03-18
RGC [bearish]
Regencell Bioscience Holdings Limited
-2375.02%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong.
Market Cap
$797.0M
Pitch Price
$0.70
Price Target
8.00 (-52%)
Dividend
N/A
EV/EBITDA
-197.73
P/E
-185.28
EV/Sales
N/A
Sector
Pharmaceuticals
Category
N/A
Show full summary:
Regencell Bioscience Holdings Limited - $RGC (short)
RGC short: TCM company at $27 with $5.2M cash left, burning $1-2M/quarter. Zero revenue, $350M EV. Up from $4 to $28 in a week. Faces scientific validation risks, regulatory hurdles, and extreme dependence on CEO's father as sole TCM practitioner. Dilutive financing likely within 6 months. Target $8.
Read full article (3 min)